Canakinumab Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with canakinumab
I
- Ibrance (palbociclib)
- ibritumomab
- ibrutinib
- Ibudone (hydrocodone / ibuprofen)
- ibuprofen / oxycodone
- Iclevia (ethinyl estradiol / levonorgestrel)
- Iclusig (ponatinib)
- Idacio (adalimumab)
- Idamycin (idarubicin)
- Idamycin PFS (idarubicin)
- idarubicin
- idecabtagene vicleucel
- idelalisib
- Ifex (ifosfamide)
- Ifex / Mesnex (ifosfamide / mesna)
- ifosfamide
- ifosfamide / mesna
- Ilumya (tildrakizumab)
- imatinib
- Imbruvica (ibrutinib)
- Imdelltra (tarlatamab)
- imetelstat
- Imfinzi (durvalumab)
- Imlygic (talimogene laherparepvec)
- Imovax Rabies (rabies vaccine, human diploid cell)
- Implanon (etonogestrel)
- Imuran (azathioprine)
- In-111 Zevalin (ibritumomab)
- Incassia (norethindrone)
- inebilizumab
- Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- Inflectra (infliximab)
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- Infugem (gemcitabine)
- Innovar (droperidol / fentanyl)
- inotuzumab ozogamicin
- Inqovi (cedazuridine / decitabine)
- Intestinex (lactobacillus acidophilus)
- Introvale (ethinyl estradiol / levonorgestrel)
- iobenguane I 131
- Iodal HD (chlorpheniramine / hydrocodone / phenylephrine)
- iodine i 131 tositumomab
- Ionsys (fentanyl)
- Iotussin D Liquid (hydrocodone / pseudoephedrine)
- Iotussin HC (chlorpheniramine / hydrocodone / phenylephrine)
- Ipol (poliovirus vaccine, inactivated)
- iptacopan
- irinotecan
- irinotecan liposomal
- isatuximab
- Isibloom (desogestrel / ethinyl estradiol)
- isradipine
- Istodax (romidepsin)
- Iwilfin (eflornithine)
- ixabepilone
- ixazomib
- Ixchiq (chikungunya vaccine, live (cvx 317))
- ixekizumab
- Ixempra (ixabepilone)
- Ixiaro (japanese enceph vacc sa14-14-2, inactivated)
- Ixifi (infliximab)
More about canakinumab
- canakinumab consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.